Nerandomilast is posed to be Boehringer Ingelheim’s successor to its blockbuster Ofev (nintedanib)in IPF and PPF.
Bloom Investment Counsel, Inc. (the “Manager”), the manager of Bloom Select Income Fund (TSX: BLB.UN) (the “Fund”), announced on January 13, 2025 that the Fund will terminate on March 5, 2025 (the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback